AKT1 and cancer: Various cancer-related and angiogenesis signaling pathways, such as PI3K/AKT/mTOR11,15 SRC/MAPKs/AP-124, TLR4/NF-κB/MMP-916, and VEGF/VEGFR2/AKT19 are also controlled by andrographolide.